Why the study?
Is an elevated pan-immune-inflammation value associated with increased mortality in patients with hypertension?
Is an elevated pan-immune-inflammation value associated with increased mortality in patients with hypertension?
The pan-immune-inflammation value may serve as a prognostic biomarker for long-term mortality risk in patients with hypertension.
May support PIV monitoring for mortality risk in hypertension; leaves open its added value beyond standard predictors.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: